Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$274.90 USD

274.90
1,518,178

+3.90 (1.44%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $275.00 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (228 out of 244)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Tanuka De headshot

6 Insurers to Hit High Notes in Q3 on Several Positives

by Tanuka De

We zero in on six insurance stocks, poised to exceed expectations in Q3, backed by several tailwinds despite Hurricane Florence weighing on underwriting profitability.

    Ritujay Ghosh headshot

    Employer Sponsored Health Insurance Premiums Jump: 4 Picks

    by Ritujay Ghosh

    An increasing number of memberships, with unemployment rate hitting a record low, have been one of the prime factors behind the top-line growth of the health insurance sector.

      Zacks Equity Research

      5 Stocks With High Net Income Ratio to Scoop Up

      by Zacks Equity Research

      Profitability analysis is one of the best ways to evaluate the prospects of a company

        Zacks Equity Research

        Cigna Gets Merger Nod, Forms Management for Unified Entity

        by Zacks Equity Research

        Cigna (CI) forms management as it prepares for new merged entity.

          Zacks Equity Research

          Cigna, First Solar, Stitch Fix, Pepsico and Costco Wholesale highlighted as Zacks Bull and Bear of the Day

          by Zacks Equity Research

          Cigna, First Solar, Stitch Fix, Pepsico and Costco Wholesale highlighted as Zacks Bull and Bear of the Day

            Zacks Equity Research

            Zacks.com highlights: Lululemon Athletica, Nucor, Quaker Chemical, Cigna and Global Brass and Copper Holdings

            by Zacks Equity Research

            Zacks.com highlights: Lululemon Athletica, Nucor, Quaker Chemical, Cigna and Global Brass and Copper Holdings

              Sapna Bagaria headshot

              4 Health Insurance Stocks Poised for Earnings Beat in Q3

              by Sapna Bagaria

              Higher enrollment, premium increase, cost management and share buyback should aid health insurers' earnings in the third quarter, partly offset by higher operating costs.

                Zacks Equity Research

                5 Top Momentum Stocks Based on Driehaus Strategy

                by Zacks Equity Research

                Richard Herman Driehaus developed an investment strategy per the buy high and sell higher principle

                  Ryan McQueeney headshot

                  Bull of the Day: Cigna (CI)

                  by Ryan McQueeney

                  Play this insurance giant ahead of its mega merger.

                    Zacks Equity Research

                    Moving Average Crossover Alert: Cigna (CI)

                    by Zacks Equity Research

                    Cigna Corporation (CI) is looking like an interesting pick from a technical perspective

                      Tirthankar Chakraborty headshot

                      New Strong Buy Stocks for September 26th

                      by Tirthankar Chakraborty

                      Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday

                        Zacks Equity Research

                        Cigna's (CI) Subsidiary Receives Rating Actions From Moody's

                        by Zacks Equity Research

                        Cigna's (CI) arm Halfmoon Parent gets credit ratings from Moody's Investors Service.

                          Zacks Equity Research

                          Humana (HUM) Expands Pact With Fitbit to Rein in Claim Cost

                          by Zacks Equity Research

                          Humana (HUM) expands its wellness program to manage claim cost and members' health.

                            Zacks Equity Research

                            Cigna Moves Closer to Express Scripts Buyout With DoJ Nod

                            by Zacks Equity Research

                            Cigna (CI) clears a significant regulatory hurdle with regards to its proposed acquisition of Express Scripts.

                              Zacks Equity Research

                              8 GARP Stocks to Scoop Up for Maximum Returns

                              by Zacks Equity Research

                              If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

                                Zacks Equity Research

                                Assurant (AIZ) Promises to Offer Better Returns: Apt to Add?

                                by Zacks Equity Research

                                Assurant (AIZ) ensures a better reward for investors on the back of seven factors.

                                  Zacks Equity Research

                                  Cboe Global Markets Stock in Growth Groove: Wise to Hold?

                                  by Zacks Equity Research

                                  Cboe Global Markets (CBOE) remains well-positioned for growth on the back of global reach with potent proprietary products.

                                    Zacks Equity Research

                                    8 GARP Stocks for a Winning Portfolio

                                    by Zacks Equity Research

                                    Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.

                                      Zacks Equity Research

                                      Hartford Financial to Expand Business Via Navigators Buyout

                                      by Zacks Equity Research

                                      Hartford Financial (HIG) inks a deal for Navigators Group's purchase to boost its product portfolio and service offerings.

                                        Zacks Equity Research

                                        UnitedHealth to Spread in Pharmacy Business With Genoa Deal

                                        by Zacks Equity Research

                                        UnitedHealth's (UNH) acquisition of Genoa Health should aid the company's Optum segment.

                                          Zacks Equity Research

                                          Will AIG Stock Rebound From 3% Decline Since 2Q Earnings?

                                          by Zacks Equity Research

                                          AIG stock has lost its shine after missing second-quarter earnings estimate.

                                            Nitish Marwah headshot

                                            Trump Boosts Short-Term Health Plans: Top 4 Insurance Plays

                                            by Nitish Marwah

                                            Trump's latest push to provide an alternative to the ACA would provide millions of Americans the freedom to choose their own health policies.

                                              Zacks Equity Research

                                              Company News For Aug 3, 2018

                                              by Zacks Equity Research

                                              Companies in the news are: CI, TSLA, TEVA and REGN

                                                Zacks Equity Research

                                                Trade War Fears Haunt Investors Again

                                                by Zacks Equity Research

                                                Trade War Fears Haunt Investors Again

                                                  Zacks Equity Research

                                                  Cigna (CI) Q2 Earnings & Revenues Beat, 2018 View Raised

                                                  by Zacks Equity Research

                                                  Cigna's (CI) Q2 earnings gain on premium and customer growth.